We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

73 hedge funds and large institutions have $21.1M invested in T2 Biosystems, Inc in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more call options, than puts

Call options by funds: $470K | Put options by funds: $379K

7% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 14

6% less funds holding

Funds holding: 7873 (-5)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

39% less capital invested

Capital invested by funds: $34.6M → $21.1M (-$13.5M)

Holders
73
Holders Change
-5
Holders Change %
-6.41%
% of All Funds
1.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
13
Reduced
14
Closed
12
Calls
$470K
Puts
$379K
Net Calls
+$91K
Net Calls Change
-$22K

TTOO Hedge Fund Activity: Q3 2021 in Review

73 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2021, worth a combined $21.1M — down 39% from $34.6M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of TTOO and 9 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 13 added.

The largest buyer was Natixis, opening a new position worth an estimated $539K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.66M sold.

  • 73 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2021, down from 78 in Q2 2021.
  • Funds reported $21.1M of T2 Biosystems, Inc stock for Q3 2021, down 39% quarter-over-quarter.
  • 9 funds opened new T2 Biosystems, Inc positions in Q3 2021 and 12 closed out, a net change of -3 holders.
  • The largest T2 Biosystems, Inc buyer in Q3 2021 was Natixis, an estimated $539K added.
  • The largest T2 Biosystems, Inc seller in Q3 2021 was Renaissance Technologies, an estimated $2.66M sold.

Based on aggregated 13F filings for Q3 2021.